Published
Combining NVIDIA's world-leading accelerated computing and Schrödinger's novel drug discovery platform enables rapid, accurate evaluation of billions of molecules for the potential development of therapeutics, reducing the cost of preclinical drug discovery. Learn more: https://nvda.ws/3fUH2JF
#drugresearch #drugdevelopment #machinelearning
#drugresearch #drugdevelopment #machinelearning
Be the first to comment
Up Next
Autoplay
-
01:14
GSK and NVIDIA Partner on AI-Powered Lab for Discovery of Medicines and Vaccines
-
03:29
U.S. Building 2 Flagship Supercomputers to Accelerate Scientific Discovery
-
00:40
Drug Discovery Set for Deep Learning Transformation Powered by GPUs
-
03:32
U.S. Building Two Flagship Supercomputers to Accelerate Scientific Discovery
-
02:24
Accelerate AI-Powered Drug Discovery With NVIDIA BioNeMo
-
02:20
AstraZeneca: Accelerating Drug Discovery with Machine Learning and AI on Cambridge-1
-
02:31
2019 AMD Cares Day of Service: Strengthening Communities Worldwide
-
01:39
Harnessing the Scale of Cloud to Accelerate Drug Discovery
-
02:06
NVIDIA and Arm Accelerate HPC Worldwide
-
01:19
Using AI to Accelerate Scientific Discovery
-
01:31
Interactive Visualization of High-Resolution, Global-Scale Climate Data in the Cloud
-
02:20
Generating Potential Accident Scenarios for Autonomous Vehicles Using AI - NVIDIA DRIVE Labs Ep. 27
-
00:34
NVIDIA GTC 2023 Keynote Teaser
-
02:13
Experience Hospitality Design on CloudXR with AWS
-
1:17:52
GTC 2023 Keynote with NVIDIA CEO Jensen Huang
-
02:48
BMW Group Celebrates Opening the World's First Virtual Factory in NVIDIA Omniverse
-
02:31
NVIDIA Omniverse Foundational Technology Montage I GTC Spring 2023 Edition
-
02:03
Amazon Robotics Deploys First Fully Autonomous Robot With NVIDIA Isaac Sim
-
02:04
Easily Scale and Unify Industrial Digitalization With NVIDIA Omniverse Cloud
-
03:14
I AM AI | NVIDIA GTC 2023 | Official Keynote Intro